AKT1 and cancer: Interestingly, we identified targets and pathways that are associated with cancer evolution, development, and progression; specifically, central carbon metabolism in malignancy, resistance to EGFR tyrosine kinase inhibitors, apoptosis, and the PI3K-AKT signaling pathways.